Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect

References

• Hoffman JI, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-term follow-up. Am J Cardiol. 1978;42(4):641–647.
   PubMed Web of Science ®Google Scholar
• Tegnander E, Eik-Nes SH, Johansen OJ, et al. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol. 1995;5(6):372–380.
   PubMed Web of Science ®Google Scholar
• Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–1900.
   PubMed Web of Science ®Google Scholar
• Allan L, Benacerraf B, Copel JA, et al. Isolated major congenital heart disease. Ultrasound Obstet Gynecol. 2001;17(5):370–379.
   PubMed Web of Science ®Google Scholar
• Tankeu AT, Bigna JJ, Nansseu JR, et al. Prevalence and patterns of congenital heart diseases in Africa: a systematic review and meta-analysis protocol. BMJ Open. 2017;7(2):e015633.
   PubMed Web of Science ®Google Scholar
• Rosano A, Botto LD, Botting B, et al. Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J Epidemiol Community Health. 2000;54(9):660–666.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects – United States, 2003. Morb Mortal Wkly Rep. 2007;56(2):25–29.
   PubMedGoogle Scholar
• American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med. 2013;32(6):1083–1101.
   PubMedGoogle Scholar
• Pinto NM, Keenan HT, Minich LL, et al. Barriers to prenatal detection of congenital heart disease: a population-based study. Ultrasound Obstet Gynecol. 2012;40(4):418–425.
   PubMed Web of Science ®Google Scholar
• Stoll C, Garne E, Clementi M, et al. Evaluation of prenatal diagnosis of associated congenital heart diseases by fetal ultrasonographic examination in Europe. Prenat Diagn. 2001;21(4):243–252.
   PubMed Web of Science ®Google Scholar
• Fung A, Manlhiot C, Naik S, et al. Impact of prenatal risk factors on congenital heart disease in the current era. J Am Heart Assoc. 2013;2(3):e000064.
   PubMed Web of Science ®Google Scholar
• Hunter LE, Simpson JM. Prenatal screening for structural congenital heart disease. Nat Rev Cardiol. 2014;11(6):323–334.
   PubMed Web of Science ®Google Scholar
• Sharland G. Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all? Future Cardiol. 2012;8(2):189–202.
   PubMedGoogle Scholar
• Tworetzky W, McElhinney DB, Reddy VM, et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation. 2001;103(9):1269–1273.
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37:D603–D610.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim SH, Kim JH, et al. Understanding metabolomics in biomedical research. Endocrinol Metab. 2016;31(1):7–16.
   Google Scholar
• Wishart DS. Computational approaches to metabolomics. Methods Mol Biol. 2010;593:283–313.
   PubMedGoogle Scholar
• Bahado-Singh RO, Ertl R, Mandal R, et al. Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014;211(3):240.e1–240.e14.
   PubMed Web of Science ®Google Scholar
• Xie D, Luo Y, Xiong X, et al. Study on the potential biomarkers of maternal urine metabolomics for fetus with congenital heart diseases based on modified gas chromatograph–mass spectrometer. Biomed Res Int. 2019;2019:1905416.
   PubMed Web of Science ®Google Scholar
• Xia J, Mandal R, Sinelnikov IV, et al. MetaboAnalyst 2.0—a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 2012;40(W1):W127–W133.
   PubMed Web of Science ®Google Scholar
• Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc B (Methodological). 1996;58(1):267–288.
   Web of Science ®Google Scholar
• Xia J, Psychogios N, Young N, et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37(Suppl. 2):W652–W660.
   PubMedGoogle Scholar
• Finnell RH, Spiegelstein O, Wlodarczyk B, et al. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr. 2002;132(8 Suppl.):2457S–2461S.
   PubMed Web of Science ®Google Scholar
• Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA. 1996;93(26):15227–15232.
   PubMed Web of Science ®Google Scholar
• Hobbs CA, Cleves MA, Melnyk S, et al. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr. 2005;81(1):147–153.
   PubMed Web of Science ®Google Scholar
• Kapusta L, Haagmans ML, Steegers EA, et al. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr. 1999;135(6):773–774.
   PubMed Web of Science ®Google Scholar
• Shawky RM, Ramy ARM, El-Din SMN, et al. Abnormal maternal biomarkers of homocysteine and methionine metabolism and the risk of congenital heart defects. Egypt J Med Hum Genet. 2018;19(1):7–12.
   Google Scholar
• Yu M, Sun S, Yu J, et al. Discovery and validation of potential serum biomarkers for pediatric patients with congenital heart diseases by metabolomics. J Proteome Res. 2018;17(10):3517–3525.
   PubMed Web of Science ®Google Scholar
• Mao B, Qiu J, Zhao N, et al. Maternal folic acid supplementation and dietary folate intake and congenital heart defects. PLoS One. 2017;12(11):e0187996.
   PubMed Web of Science ®Google Scholar
• Hassan MH, Farouk A, Elbadre HM, et al. Phospholipids and l-carnitine screening in children with congenital heart diseases undergoing surgical correction. Int Ann Med. 2017;2(1).
   Google Scholar
• Vance JE. Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J Lipid Res. 2008;49:1377–1387.
   PubMed Web of Science ®Google Scholar
• da Costa KA, Badea M, Fischer LM, et al. Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts. Am J Clin Nutr. 2004;80(1):163–170.
   PubMed Web of Science ®Google Scholar
• Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229–250.
   PubMed Web of Science ®Google Scholar
• Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine metabolism in health and disease. Int Rev Cell Mol Biol. 2016;321:29–88.
   PubMed Web of Science ®Google Scholar
• Lim HY, Bodmer R. Phospholipid homeostasis and lipotoxic cardiomyopathy: a matter of balance. Fly. 2011;5(3):234–236.
   PubMed Web of Science ®Google Scholar
• Lim HY, Wang W, Wessells RJ, et al. Phospholipid homeostasis regulates lipid metabolism and cardiac function through SREBP signaling in Drosophila. Genes Dev. 2011;25(2):189–200.
   PubMed Web of Science ®Google Scholar
• Gittenberger-de Groot AC, Bartelings MM, Deruiter MC, et al. Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res. 2005;57(2):169–176.
   PubMed Web of Science ®Google Scholar